Cargando…

Retraction Note: Silencing of TRIM11 suppresses the tumorigenicity of chordoma cells through improving the activity of PHLPP1/AKT

Detalles Bibliográficos
Autores principales:	Wang, Bin, Wang, Gang, Wang, Qingfeng, Zhu, Ziqiang, Wang, Yunqing, Chen, Kangwu, Yang, Huilin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Retraction Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523747/ https://www.ncbi.nlm.nih.gov/pubmed/37752515 http://dx.doi.org/10.1186/s12935-023-03017-2

Ejemplares similares

Silencing of TRIM11 suppresses the tumorigenicity of chordoma cells through improving the activity of PHLPP1/AKT
por: Wang, Bin, et al.
Publicado: (2019)

Retraction Note: TRIM11 overexpression promotes proliferation, migration and invasion of lung cancer cells
por: Wang, Xiaolin, et al.
Publicado: (2023)

Retraction Note
Publicado: (2016)

Retraction Note
Publicado: (2016)

Retraction Note
Publicado: (2018)

Retraction Note: TRIM25 blockade by RNA interference inhibited migration and invasion of gastric cancer cells through TGF-β signaling
por: Zhu, Zhenya, et al.
Publicado: (2023)

iNOS is Associated with Tumorigenicity as an Independent Prognosticator in Human Intrahepatic Cholangiocarcinoma [Retraction]
Publicado: (2023)

Retraction Note: TRIM29 facilitates the epithelial‑to-mesenchymal transition and the progression of colorectal cancer via the activation of the Wnt/β-catenin signaling pathway
por: Sun, Juntao, et al.
Publicado: (2022)

Retraction: Fingolimod inhibits proliferation and epithelial- mesenchymal transition in sacral chordoma by inactivating IL-6/STAT3 signaling
Publicado: (2020)

Retraction Notice to: ANXA3 Silencing Ameliorates Intracranial Aneurysm via Inhibition of the JNK Signaling Pathway
por: Wang, Yang, et al.
Publicado: (2022)

Retracted: miR-181a Ameliorates the Progression of Myasthenia Gravis by Regulating TRIM9
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Retracted: TRIM44 Promotes Endometrial Carcinoma Progression by Activating the FRS2 Signalling Pathway
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

LncRNA-NONHSAT024778 promote the proliferation and invasion of chordoma cell by regulating miR-1290/Robo1 axis
por: Wang, Bin, et al.
Publicado: (2021)

Retraction Note: Effects of CREB1 gene silencing on cognitive dysfunction by mediating PKA-CREB signaling pathway in mice with vascular dementia
por: Han, Xin-Rui, et al.
Publicado: (2023)

miR-1290 inhibits chordoma cell proliferation and invasion by targeting Robo1
por: Wang, Bin, et al.
Publicado: (2019)

Retraction Notice to: Silencing of Long Non-coding RNA RP1-93H18.6 Acts as a Tumor Suppressor in Cervical Cancer through the Blockade of the PI3K/Akt Axis
por: Wang, Qian, et al.
Publicado: (2022)

GATA1 Gene Silencing Inhibits Invasion, Proliferation and Migration of Cholangiocarcinoma Stem Cells via Disrupting the PI3K/AKT Pathway [Retraction]
Publicado: (2021)

Silencing of Long Non-Coding RNA-HCG18 Inhibits the Tumorigenesis of Gastric Cancer Through Blocking PI3K/Akt Pathway [Retraction]
Publicado: (2020)

Retraction Note: Tripartite motif-containing 14 (TRIM14) promotes epithelial-mesenchymal transition via ZEB2 in glioblastoma cells
por: Feng, Shuang, et al.
Publicado: (2023)

Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers: Retraction
Publicado: (2015)

RETRACTION NOTICE: miR-152 inhibits the proliferation and invasion of chordoma cells by targeting HOXC8
Publicado: (2021)

Retraction Note: Resveratrol rescues hyperglycemia-induced endothelial dysfunction via activation of Akt
por: Li, Jin-yi, et al.
Publicado: (2020)

Retraction Note: MicroRNA-203 suppresses gastric cancer growth by targeting PIBF1/Akt signaling
por: Chu, Shao-Jun, et al.
Publicado: (2017)

Retraction Note: TLE3 represses colorectal cancer proliferation by inhibiting MAPK and AKT signaling pathways
por: Yang, Run-Wei, et al.
Publicado: (2021)

Retraction Note: Alpha-ketoglutarate promotes skeletal muscle hypertrophy and protein synthesis through Akt/mTOR signaling pathways
por: Cai, Xingcai, et al.
Publicado: (2020)

[Retracted] Silencing cyclin‑dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines
por: Deng, Miao, et al.
Publicado: (2023)

RETRACTION NOTE
Publicado: (2012)

Retraction note
por: Morina, Naser
Publicado: (2013)

RETRACTION NOTE
por: Ferrari, Giulia
Publicado: (2016)

Retraction note
Publicado: (2013)

Retraction note
Publicado: (2017)

Retraction Note: MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma
por: Liu, Zhikui, et al.
Publicado: (2022)

Transcription factor SNAI2 exerts pro-tumorigenic effects on glioma stem cells via PHLPP2-mediated Akt pathway
por: Peng, Lilei, et al.
Publicado: (2022)

Retraction Note: Ferroportin in the progression and prognosis of hepatocellular carcinoma
por: Wang, Qin, et al.
Publicado: (2015)

Retraction: SETDB1 Is Involved in Postembryonic DNA Methylation and Gene Silencing in Drosophila
Publicado: (2018)

Retraction Note: GDF11 enhances therapeutic functions of mesenchymal stem cells for angiogenesis
por: Zhang, Chi, et al.
Publicado: (2023)

TRIM46 activates AKT/HK2 signaling by modifying PHLPP2 ubiquitylation to promote glycolysis and chemoresistance of lung cancer cells
por: Tantai, Jicheng, et al.
Publicado: (2022)

Retraction note: Rituximab-conjugated, doxorubicin-loaded microbubbles as a theranostic modality in B-cell lymphoma
por: Zhou, Shoubing, et al.
Publicado: (2017)

Retracted: A Comprehensive Pan-Cancer Analysis of the Tumorigenic Effect of Leucine-Zipper-Like Transcription Regulator (LZTR1) in Human Cancer
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023)

Retraction note: Effect of probucol on autophagy and apoptosis in the penile tissue of streptozotocin-induced diabetic rats
por: Zhang, Ke-Qin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_08rt8rr46jkdl1l6sqlrejo6nd